This is very interesting.....
Watch the video, click HERE.
Getting Educated
By: Steve J. on July 5, 2011
The Compassion Chronicle is going to start educating our subscribers so that they may be more informed about the benefits of Cannabis to the human organism. There is a wealth of information out there to better our knowledge and understanding of this miraculous plant. We understand that everyone is busy with his or her personal and professional lives. With this in mind, we will give a synopsis of the articles that are presented to you as well as include documentaries for viewing. I myself have the documentary playing in the background of my computer/TV/laptop while getting other work accomplished. This really assist increasing my knowledge base… With that in mind here is a link to: “Medicinal Cannabis and its Impact on Human Health”. http://vimeo.com/20129106
The Compassion Chronicle is going to start educating our subscribers so that they may be more informed about the benefits of Cannabis to the human organism. There is a wealth of information out there to better our knowledge and understanding of this miraculous plant. We understand that everyone is busy with his or her personal and professional lives. With this in mind, we will give a synopsis of the articles that are presented to you as well as include documentaries for viewing. I myself have the documentary playing in the background of my computer/TV/laptop while getting other work accomplished. This really assist increasing my knowledge base… With that in mind here is a link to: “Medicinal Cannabis and its Impact on Human Health”. http://vimeo.com/20129106
HIV Not Accelerated by Cannabis
A 21 day University of California study showed that smoked cannabis and oral THC does not adversely affect CD4+ cell counts or viral loads in HIV-infected patients. Instead, the study led by Dr. Donald Abrams discovered positive effects of both THC and cannabis on these laboratory parameters.
The study observed sixty-seven patients with HIV-1 infection. At random they received either a placebo, a 2.5-mg dronabinol (delta-9-tetrahydrocannabinol) capsule, or 3.95%-tetrahydrocannabinol marijuana cigarette. When compared with the placebo effects, marijuana and THC users respectively experienced a 15% and 8% drop in viral loads (the amount of active HIV in a contaminated person). Furthermore, both compounds caused positive results with weight gain and increased appetite.
Sources: Abrams DI, Hilton JF, Leiser RJ, Shade SB, Elbeik TA, Aweeka FT, Benowitz NL, Bredt BM, Kosel B, Aberg JA, Deeks SG, Mitchell TF, Mulligan K, Bacchetti P, McCune JM, Schambelan M. "Short-term Effects of Cannabinoids in Patients with HIV-1 Infection: A Randomized, Placebo-controlled Clinical Trial." Annals of Internal Medicine 2003;139(4):258-266
The study observed sixty-seven patients with HIV-1 infection. At random they received either a placebo, a 2.5-mg dronabinol (delta-9-tetrahydrocannabinol) capsule, or 3.95%-tetrahydrocannabinol marijuana cigarette. When compared with the placebo effects, marijuana and THC users respectively experienced a 15% and 8% drop in viral loads (the amount of active HIV in a contaminated person). Furthermore, both compounds caused positive results with weight gain and increased appetite.
Sources: Abrams DI, Hilton JF, Leiser RJ, Shade SB, Elbeik TA, Aweeka FT, Benowitz NL, Bredt BM, Kosel B, Aberg JA, Deeks SG, Mitchell TF, Mulligan K, Bacchetti P, McCune JM, Schambelan M. "Short-term Effects of Cannabinoids in Patients with HIV-1 Infection: A Randomized, Placebo-controlled Clinical Trial." Annals of Internal Medicine 2003;139(4):258-266
Pain in Multiple Sclerosis Patients Reduced by Cannabis
At the Walton Center for Neurology and Neurosurgery in Liverpool, researchers conducted a 5-week, single-center, placebo-controlled, group trial on patients with Multiple Sclerosis. The study observed the effects of Sativex, a cannabis based oral spray. Each application transferred 2.7mg of THC and 2.5 mg of CBD, which are two active compounds produced naturally by the cannabis plant. Patients could gradually increase their dosage to a maximum of 48 sprays in a 24-hour period.
The study found reductions in both sleep disturbance and central neuropathic pain. Published in the journal Neurology, this led to the spray's approval in Canada as a prescription medicine. Manufactured by GW Pharmaceuticals, Sativex became available in June 20, 2005.
Sources: Rog DJ, Nurmikko TJ, Friede T, Young CA. "Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis". Neurology 2005;65(6):812-9;
The study found reductions in both sleep disturbance and central neuropathic pain. Published in the journal Neurology, this led to the spray's approval in Canada as a prescription medicine. Manufactured by GW Pharmaceuticals, Sativex became available in June 20, 2005.
Sources: Rog DJ, Nurmikko TJ, Friede T, Young CA. "Randomized, controlled trial of cannabis-based medicine in central pain in multiple sclerosis". Neurology 2005;65(6):812-9;
PUFMM website, click HERE.
Use the SEARCH field on this blog site to browse other topics: Education, Charity, Poem, Writings, Music, Local.
No comments:
Post a Comment